Downregulation of MHC I (Major histocompatibility complex I), MHC II, and ICAM1 (intercellular adhesion molecule) in tumor endothelial cells suggests that the antigen presentation and homing abilities of immune cells are decreased, thereby promoting tumor immune tolerance. This evidence concerns the gene ICAM1 and neoplasm.